NCT05236569View on ClinicalTrials.gov

Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Melasma
Interventions
DRUG

Tranexamic acid injection

The tranexamic acid injection was given intradermally to the facial skin

DRUG

Injection Water

The 0.9% normal saline injection was given intradermally to the facial skin

Trial Locations (1)

10430

Dermatology and Venereology Clinic, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05236569 - Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V | Biotech Hunter | Biotech Hunter